Cargando…
Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue
Cytochrome P450 2D6 (CYP2D6) is a major drug‐metabolizing enzyme that exhibits large interindividual variability. Recent studies suggest that differential transcriptional regulation of CYP2D6 in part may be responsible for the variability. In this study, we characterized potential determinants of CY...
Autores principales: | Ning, Miaoran, Duarte, Julio D., Stevison, Faith, Isoherranen, Nina, Rubin, Leah H., Jeong, Hyunyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618095/ https://www.ncbi.nlm.nih.gov/pubmed/30821899 http://dx.doi.org/10.1111/cts.12632 |
Ejemplares similares
-
Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug‐Drug Interactions? Preclinical and Clinical Studies With 13‐cis‐Retinoic Acid
por: Stevison, Faith, et al.
Publicado: (2019) -
Role of cytochrome P450 genotype in the steps toward personalized drug therapy
por: Cavallari, Larisa H, et al.
Publicado: (2011) -
17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor α
por: Cho, Sung-joon, et al.
Publicado: (2016) -
Hepatic Metabolism of Sakuranetin and Its Modulating Effects on Cytochrome P450s and UDP-Glucuronosyltransferases
por: Jeong, Hyesoo, et al.
Publicado: (2018) -
Correlation of Cytochrome P450 Oxidoreductase Expression with the
Expression of 10 Isoforms of Cytochrome P450 in Human Liver
por: Zhang, Hai-Feng, et al.
Publicado: (2016)